Investigating DNA Damage Response (DDR) Inhibition in Multiple Tumor Types - DDRiver⢠Clinical Trials Program | EMD Serono
Description
Learn about the DDRiver⢠clinical trials program, sponsored by EMD Serono, evaluating the effectiveness of two investigational drugs designed to block the DNA damage response pathway in multiple tumor types.